… low dose CEE treatment of monkeys with pre-existing atherosclerosis, initiated in the early
postmenopausal … /or, result in a reduction in atherosclerosis progression. It also seems useful …

… had an estrogen agonist effect on coronary arteries. Treatment … have the estrogen agonistic
effect of inhibiting coronary artery … On a body weight basis, our low dose of raloxifene was …

… postmenopausal female monkeys with dietinduced coronary … More recently, it was reported
(26) that estrogen inhibits … our data indicate that lower doses of estrogen do not affect …

… The effect of estrogen and progesterone replacement … was studied in surgically
postmenopausal cynomolgus monkeys. … hormone treatment inhibits the initiation of atherosclerosis …

… influences the risk of coronary heart disease in postmenopausal women. It … coronary
artery atherosclerosis in estrogendeficient (ovariectomized) adult female cynomolgus monkeys…

… risk in postmenopausal women who do not receive estrogen … inhibiting progression of
coronary artery atherosclerosis.2 … monkeys.4,5,8,9 Our second finding was that estrogen …

… The principal findings of this study were that the potent contraceptive estrogen ethinyl E2
markedly inhibited atherosclerosis progression and that this effect was antagonized by the …

… of coronary heart disease (CHD) in postmenopausal women. … inhibiting the progression of
coronary artery atherosclerosis. … have concentrated on the lower doses of estrogen (20 to 100 …

… that postmenopausal estrogen replacement inhibits the … In this study, ovariectomized monkeys
that were treated for 30 … coronary artery atherosclerosis of postmenopausal cynomolgus …

… the coadministration of MPA (at a dose for monkeys equivalent to 2.5 mg/d … inhibition of the
development of CAA (28). In the present study there is no adverse effect on CAA inhibition by …